AzTrials
AzTrials

Estimated Age Calculated Based on Modified Demirjian Method Using Mandibular Left Third MolarNCT06232135

Assessment of Reliability of Demirjian Formula for Age Estimation Using Mandibular Third Molar in a Sample of Egyptian Population Using CBT: a Cross-sectional Study

An observational study of Estimated Age Calculated Based on Modified Demirjian Method Using Mandibular Left Third Molar, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Aim: To assess the reliability of age estimation in Egyptian adolescents and young adults using mandibular third molar stages of calcification, based on the Demirjian method, on CBCT scans. Read more about this study

Who is it for?
Ages 9 to 24 years
What is being tested?
CBCT scan
How many people
145 participants
Where
1 siteEgypt
Study dates
1 Sep 2021to 15 Jun 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 9 to 24 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: CBCT scans from the database available at the department of Oral and Maxillofacial Radiology, Faculty of Dentistry, Cairo University.

Who may be able to join

  • Egyptian patients with age ranges from 9 to 24 years.
  • Complete dental records of radiographs, including the date of birth, date of radiography, and sex.
  • Scans showing complete mandibular arch.

Who cannot join

  • Patients below 9 years and above 24 years.
  • Any pathology or fractures associated with mandibular third molar.
  • Scans with severe metallic artifacts.
  • Congenitally absent 3rd molars.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • faculty of dentistry - Cairo university

    Cairo, Cairo Governorate, 3753450

Other trials in Egypt

About this study

Aim: To assess the reliability of age estimation in Egyptian adolescents and young adults using mandibular third molar stages of calcification, based on the Demirjian method, on CBCT scans.

Methodology: 145 CBCT scans for the mandibular left posterior region were collected from the database of the maxillofacial radiology clinic of the faculty of dentistry at Cairo University. The scans were then analyzed using Planmeca Romexis software viewer version 4.6.2.R. The mandibular left 3rd molars were evaluated to determine the calcification stage of each of them based on the modified Demirjian method. According to the assigned calcification stage, the dental age was determined, and then the mean ± SD for each calcification stage was calculated and compared to the chronological age in terms of mean difference and mean absolute error. The correlation between the calculation stage and chronological age was analyzed, and the probability for an individual to be 18 years of age or older in each stage was calculated.

Read the detailed description

this is a cross-sectional study.

The data collection will be obtained from the database available at the Department of Oral and Maxillofacial Radiology, Faculty of Dentistry, Cairo University. CBCT images will be obtained from Egyptian patients who were referred to the CBCT unit in the oral and maxillofacial radiology departments for different purposes.

  • Retrospective Data Analysis will be performed after the CBCT images are pooled from the computer database.
  • Exposure parameters of the scans will vary depending on patients' sizes (according to the manufacturer's recommendations).
  • Images with 0.4 voxel size or less will be reviewed.
  • Evaluation of the calcification of third molar will be done using the reformatted panoramic view of CBCT scans and will be compared with the Demirjian chart (8 stage grading scheme for third molar).
  • The third molars from the lower left quadrants will be assessed and categorized into their respective developmental stages given by Demirjian.
  • CBCT images will be interpreted by two oral and maxillofacial radiologists (with different experiences) independently; blinded from demographic data of the patients and from the results of each other.
  • Each radiologist will evaluate the images for proper determination of the third molar calcification stage and to decide the dental age of the patient according the chart provided by demirjian et al.
  • The calcification stage determination will be carried out by one observer and will be repeated later for intra-observer reliability assessment.
  • Any disagreement will be solved by consensus between the two observers.
  • The chronological age recorded based on his/her date of birth will be correlated with developmental stages of third molar.

The two oral and maxillofacial radiologists interpreting the scans will be blinded from demographic data of the patients and from the results of each other.

A power analysis was designed to have adequate power to apply a statistical test of the null hypothesis that there is no difference would be found between chronological age and developmental age of third molar according to modified Demirjian chart. By adopting an alpha level of (0.05) a beta of (0.2) i.e. power=80% and an effect size (d) of (0.26) calculated based on the results of Mohammed, Rezwana Begum, et al. ; the predicted sample size (n) was a total of (117) cases. Sample size calculation was performed using G*Power version 3.1.9.7 Numerical data will be explored for normality by checking the data distribution, calculating the mean and median values and using Kolmogorov-Smirnov and Shapiro-Wilk tests. If the data was found to be normally distributed, it will be presented as mean and standard deviation values. If the assumption of normality was found to be violated, the data will be presented as median and range values.

Categorical data will be represented as frequency (n) and percentage (%). Categorical data will be represented as frequency (n) and percentage (%) and will be analyzed using chi square test. Numerical data will be explored for normality by checking the data distribution, calculating the mean and median values and using Kolmogorov-Smirnov and Shapiro-Wilk tests. If the data was found to be normally distributed, it will be presented as mean and standard deviation values and Paired t-test will be used for the analysis. If the assumption of normality was found to be violated; the data will be presented as median and range values and will be analyzed using Wilcoxon signed-rank test. The significance level will be set at p ≤0.05 for all tests. Statistical analysis will be performed with IBM® SPSS® Statistics Version 26 for Windows.

Being tested
CBCT scan
Keywords
Demirjian, CBCT, age estimation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CBCT scanOther

    analysis of the CBCT scan to assign a calcification stage to the subject's lower left third molar and accordingly calculate the estimated age of each subject

Study groups in NCT06232135
Study groupRoleWhat they receive
FemalesCBCT scans of the females enrolled in the study are to be analyzed for the assignment of a calcification stage to their lower left third molar according to the modified Demirjian method.
Receives: Other: CBCT scan
MalesCBCT scans of the males enrolled in the study are to be analyzed for the assignment of a calcification stage to their lower left third molar according to the modified Demirjian method.
Receives: Other: CBCT scan

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. accuracy of the modified Demirjian method

    mean difference between estimated age and chronological age

    Measured: 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2024
  2. Study start1 Sep 2021
  3. Primary completion15 Jun 2022
  4. Study completion15 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrolment
145 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06232135
Sponsor's protocol ID
yaraprotocol1893
Status last verified
Jan 2024
First submitted
20 Jan 2024
Last updated
30 Jan 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: The age and gender of the participants will be shared. If further information is required, then the invistigator will decide what to share so as not to violate patient privacy.

Questions about this trial

What is this clinical trial studying?

An observational study of Estimated Age Calculated Based on Modified Demirjian Method Using Mandibular Left Third Molar, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

accuracy of the modified Demirjian method (time frame: 2 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT06232135 | AzTrials